Literature DB >> 23334168

Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface.

Anna Salvati1, Andrzej S Pitek, Marco P Monopoli, Kanlaya Prapainop, Francesca Baldelli Bombelli, Delyan R Hristov, Philip M Kelly, Christoffer Åberg, Eugene Mahon, Kenneth A Dawson.   

Abstract

Nanoparticles have been proposed as carriers for drugs, genes and therapies to treat various diseases. Many strategies have been developed to target nanomaterials to specific or over-expressed receptors in diseased cells, and these typically involve functionalizing the surface of nanoparticles with proteins, antibodies or other biomolecules. Here, we show that the targeting ability of such functionalized nanoparticles may disappear when they are placed in a biological environment. Using transferrin-conjugated nanoparticles, we found that proteins in the media can shield transferrin from binding to both its targeted receptors on cells and soluble transferrin receptors. Although nanoparticles continue to enter cells, the targeting specificity of transferrin is lost. Our results suggest that when nanoparticles are placed in a complex biological environment, interaction with other proteins in the medium and the formation of a protein corona can 'screen' the targeting molecules on the surface of nanoparticles and cause loss of specificity in targeting.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23334168     DOI: 10.1038/nnano.2012.237

Source DB:  PubMed          Journal:  Nat Nanotechnol        ISSN: 1748-3387            Impact factor:   39.213


  33 in total

Review 1.  The role of transferrin in the mechanism of cellular iron uptake.

Authors:  K Thorstensen; I Romslo
Journal:  Biochem J       Date:  1990-10-01       Impact factor: 3.857

2.  Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation.

Authors:  Zhou J Deng; Mingtao Liang; Michael Monteiro; Istvan Toth; Rodney F Minchin
Journal:  Nat Nanotechnol       Date:  2010-12-19       Impact factor: 39.213

3.  Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles.

Authors:  Tommy Cedervall; Iseult Lynch; Stina Lindman; Tord Berggård; Eva Thulin; Hanna Nilsson; Kenneth A Dawson; Sara Linse
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-31       Impact factor: 11.205

4.  Soft interactions at nanoparticles alter protein function and conformation in a size dependent manner.

Authors:  Jing Wang; Uffe B Jensen; Grethe V Jensen; Stepan Shipovskov; Vijay S Balakrishnan; Daniel Otzen; Jan Skov Pedersen; Flemming Besenbacher; Duncan S Sutherland
Journal:  Nano Lett       Date:  2011-10-11       Impact factor: 11.189

5.  Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile.

Authors:  Jeffrey Hrkach; Daniel Von Hoff; Mir Mukkaram Ali; Elizaveta Andrianova; Jason Auer; Tarikh Campbell; David De Witt; Michael Figa; Maria Figueiredo; Allen Horhota; Susan Low; Kevin McDonnell; Erick Peeke; Beadle Retnarajan; Abhimanyu Sabnis; Edward Schnipper; Jeffrey J Song; Young Ho Song; Jason Summa; Douglas Tompsett; Greg Troiano; Tina Van Geen Hoven; Jim Wright; Patricia LoRusso; Philip W Kantoff; Neil H Bander; Christopher Sweeney; Omid C Farokhzad; Robert Langer; Stephen Zale
Journal:  Sci Transl Med       Date:  2012-04-04       Impact factor: 17.956

6.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles.

Authors:  Mark E Davis; Jonathan E Zuckerman; Chung Hang J Choi; David Seligson; Anthony Tolcher; Christopher A Alabi; Yun Yen; Jeremy D Heidel; Antoni Ribas
Journal:  Nature       Date:  2010-03-21       Impact factor: 49.962

7.  Covalently dye-linked, surface-controlled, and bioconjugated organically modified silica nanoparticles as targeted probes for optical imaging.

Authors:  Rajiv Kumar; Indrajit Roy; Tymish Y Ohulchanskyy; Lalit N Goswami; Adela C Bonoiu; Earl J Bergey; Kenneth M Tramposch; Anirban Maitra; Paras N Prasad
Journal:  ACS Nano       Date:  2008-03       Impact factor: 15.881

8.  Bio-molecule-conjugated fluorescent organically modified silica nanoparticles as optical probes for cancer cell imaging.

Authors:  Jun Qian; Xin Li; Ming Wei; Xiangwei Gao; Zhengping Xu; Sailing He
Journal:  Opt Express       Date:  2008-11-24       Impact factor: 3.894

9.  The transferrin receptor: a potential molecular imaging marker for human cancer.

Authors:  Dagmar Högemann-Savellano; Erik Bos; Cyrille Blondet; Fuminori Sato; Tatsuya Abe; Lee Josephson; Ralph Weissleder; Justin Gaudet; Dennis Sgroi; Peter J Peters; James P Basilion
Journal:  Neoplasia       Date:  2003 Nov-Dec       Impact factor: 5.715

10.  Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.

Authors:  Edward Keystone; Désireé van der Heijde; David Mason; Robert Landewé; Ronald Van Vollenhoven; Bernard Combe; Paul Emery; Vibeke Strand; Philip Mease; Chintu Desai; Karel Pavelka
Journal:  Arthritis Rheum       Date:  2008-11
View more
  330 in total

1.  Self-assembled Targeting of Cancer Cells by Iron(III)-doped, Silica Nanoparticles.

Authors:  K K Pohaku Mitchell; S Sandoval; M J Cortes-Mateos; J G Alfaro; A C Kummel; W C Trogler
Journal:  J Mater Chem B       Date:  2014-12-07       Impact factor: 6.331

Review 2.  Recent Developments in Magnetic Diagnostic Systems.

Authors:  Hakho Lee; Tae-Hyun Shin; Jinwoo Cheon; Ralph Weissleder
Journal:  Chem Rev       Date:  2015-08-10       Impact factor: 60.622

Review 3.  Protein corona: Opportunities and challenges.

Authors:  Saeid Zanganeh; Ryan Spitler; Mohsen Erfanzadeh; Alaaldin M Alkilany; Morteza Mahmoudi
Journal:  Int J Biochem Cell Biol       Date:  2016-01-16       Impact factor: 5.085

4.  An Integrative Proteomic/Lipidomic Analysis of the Gold Nanoparticle Biocorona in Healthy and Obese Conditions.

Authors:  Lisa M Kobos; Saeed Alqatani; Christina R Ferreira; Uma K Aryal; Victoria Hedrick; Tiago J P Sobreira; Jonathan H Shannahan
Journal:  Appl In Vitro Toxicol       Date:  2019-09-17

5.  Targeted PRINT Hydrogels: The Role of Nanoparticle Size and Ligand Density on Cell Association, Biodistribution, and Tumor Accumulation.

Authors:  Kevin G Reuter; Jillian L Perry; Dongwook Kim; J Christopher Luft; Rihe Liu; Joseph M DeSimone
Journal:  Nano Lett       Date:  2015-09-30       Impact factor: 11.189

6.  Protein-based photothermal theranostics for imaging-guided cancer therapy.

Authors:  Pengfei Rong; Peng Huang; Zhiguo Liu; Jing Lin; Albert Jin; Ying Ma; Gang Niu; Lun Yu; Wenbin Zeng; Wei Wang; Xiaoyuan Chen
Journal:  Nanoscale       Date:  2015-10-21       Impact factor: 7.790

7.  C1q-Mediated Complement Activation and C3 Opsonization Trigger Recognition of Stealth Poly(2-methyl-2-oxazoline)-Coated Silica Nanoparticles by Human Phagocytes.

Authors:  Regina Tavano; Luca Gabrielli; Elisa Lubian; Chiara Fedeli; Silvia Visentin; Patrizia Polverino De Laureto; Giorgio Arrigoni; Alessandra Geffner-Smith; Fangfang Chen; Dmitri Simberg; Giulia Morgese; Edmondo M Benetti; Linping Wu; Seyed Moein Moghimi; Fabrizio Mancin; Emanuele Papini
Journal:  ACS Nano       Date:  2018-05-23       Impact factor: 15.881

8.  Shrinkage of pegylated and non-pegylated liposomes in serum.

Authors:  Joy Wolfram; Krishna Suri; Yong Yang; Jianliang Shen; Christian Celia; Massimo Fresta; Yuliang Zhao; Haifa Shen; Mauro Ferrari
Journal:  Colloids Surf B Biointerfaces       Date:  2013-10-24       Impact factor: 5.268

9.  Effect of size and pegylation of liposomes and peptide-based synthetic lipoproteins on tumor targeting.

Authors:  Jie Tang; Rui Kuai; Wenmin Yuan; Lindsey Drake; James J Moon; Anna Schwendeman
Journal:  Nanomedicine       Date:  2017-04-18       Impact factor: 5.307

Review 10.  Strategies for improving drug delivery: nanocarriers and microenvironmental priming.

Authors:  Ayesha Khalid; Stefano Persano; Haifa Shen; Yuliang Zhao; Elvin Blanco; Mauro Ferrari; Joy Wolfram
Journal:  Expert Opin Drug Deliv       Date:  2016-10-11       Impact factor: 6.648

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.